National Academies Press: OpenBook

Immunization Safety Review: Influenza Vaccines and Neurological Complications (2004)

Chapter: Appendix B: Public Meeting Agenda, March 13, 2003

« Previous: Appendix A: Committee Recommendations and Conclusions from Previous Reports
Suggested Citation:"Appendix B: Public Meeting Agenda, March 13, 2003." Institute of Medicine. 2004. Immunization Safety Review: Influenza Vaccines and Neurological Complications. Washington, DC: The National Academies Press. doi: 10.17226/10822.
×
Page 168
Suggested Citation:"Appendix B: Public Meeting Agenda, March 13, 2003." Institute of Medicine. 2004. Immunization Safety Review: Influenza Vaccines and Neurological Complications. Washington, DC: The National Academies Press. doi: 10.17226/10822.
×
Page 169

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix B Public Meeting Agenda March 13, 2003 Immunization Safety Review Influenza Vaccine and Possible Neurological Complications Hotel Monaco Athens Room, 700 F St., NW Washington, DC 9:00 - 9:15 am Welcome and Opening Remarks Marie McCormick, MD, ScD, Committee Chair 9:15 - 9:45 am Influenza Robert G. Webster, PhD St. Jude Children's Research Hospital 9:45 - 10:15 am Guillain-Barre Syndrome John Griffin, MD The Johns Hopkins University School of Medicine 10:15 - 10:45 am The Yearly Production of Influenza Vaccine Roland Levandowski, MD Food and Drug Administration 10:45 - 11:00 am Break 168

APPENDIX B 11:00- 11:30 am 11:30- 12:15 pm 12:15 - 1:30 pm 1:30 - 2:15 pm 169 VAERS Reports Related to Influenza Vaccine Penina Haber,MPH Centers for Disease Control and Prevention Discussion Lunch Studies of Guillain-Barre Syndrome After Influenza Vaccination Robert Chen, MD Centers for Disease Control and Prevention 2:15 - 2:45 pm Guillain-Barre Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines Tamar Lasky, PhD National Institute of Child Health & Human Development 2:45 - 3:15 pm Safety of Influenza Vaccine in the Pediatric Population Eric K. France, MD, MSPH Preventive Medicine Kaiser Permanente Colorado 3:15 - 3:30 pm Break 3:30 - 4:00 pm Intranasal Vaccines Kathryn Edwards, MD, (presented via conference call) Vanderbilt University School of Medicine 4:00 - 4:30 pm VSD Data Related to Influenza Vaccine and Incidence/Relapse of MS Frank DeStefano, MD Centers for Disease Control and Prevention 4:30 - 4:45 pm Use of Medicare Data to Evaluate Adverse Events After Influenza Vaccine Dale Burwen, MD, Food and Drug Administration 4:45 - 5:30 pm Discussion and Public Comment 5:30 pm Adjourn

Next: Appendix C: Chronology of Important Events Regarding Vaccine Safety »
Immunization Safety Review: Influenza Vaccines and Neurological Complications Get This Book
×
Buy Paperback | $59.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Infection with the influenza virus can have a serious effect on the health of people of all ages, although it is particularly worrisome for infants, the elderly, and people with underlying heart or lung problems. A vaccine exists (the “flu” shot) that can greatly decrease the impact of influenza. Because the strains of virus that are expected to cause serious illness and death are slightly different every year, the vaccine is also slightly different every year and it must be given every year, unlike other vaccines.

The Immunization Safety Review committee reviewed the data on influenza vaccine and neurological conditions and concluded that the evidence favored rejection of a causal relationship between influenza vaccines and exacerbation of multiple sclerosis. For the other neurological conditions studied, the committee concluded the evidence about the effects of influenza vaccine is inadequate to accept or reject a causal relationship. The committee also reviewed theories on how the influenza vaccine could damage the nervous system. The evidence was at most weak that the vaccine could act in humans in ways that could lead to these neurological problems.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!